Recent Advances in the Use of Metformin: Can Treating Diabetes Prevent Breast Cancer?
出版年份 2015 全文链接
标题
Recent Advances in the Use of Metformin: Can Treating Diabetes Prevent Breast Cancer?
作者
关键词
-
出版物
Biomed Research International
Volume 2015, Issue -, Pages 1-13
出版商
Hindawi Limited
发表日期
2015-03-20
DOI
10.1155/2015/548436
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Metabolomic fingerprint reveals that metformin impairs one-carbon metabolism in a manner similar to the antifolate class of chemotherapy drugs
- (2016) Bruna Corominas-Faja et al. Aging-US
- Metformin-induced metabolic reprogramming of chemoresistant ALDHbright breast cancer cells
- (2015) Mario Cioce et al. Oncotarget
- Regulation of Metformin Response by Breast Cancer Associated Gene 2
- (2015) Daniela Buac et al. NEOPLASIA
- Triple-Negative Breast Carcinoma
- (2014) Robert Schmadeka et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- The anti-proliferative effect of metformin in triple-negative MDA-MB-231 breast cancer cells is highly dependent on glucose concentration: Implications for cancer therapy and prevention
- (2014) Beshay N.M. Zordoky et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Long-term use of metformin and the molecular subtype in invasive breast carcinoma patients – a retrospective study of clinical and tumor characteristics
- (2014) Nikola Besic et al. BMC CANCER
- Metformin enhances tamoxifen-mediated tumor growth inhibition in ER-positive breast carcinoma
- (2014) Ji Ma et al. BMC CANCER
- Phase II randomized trial of neoadjuvant metformin plus letrozole versus placebo plus letrozole for estrogen receptor positive postmenopausal breast cancer (METEOR)
- (2014) Jisun Kim et al. BMC CANCER
- The Effect of Metformin on Mortality Following Cancer among Patients with Diabetes
- (2014) I. C. Lega et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Presurgical Trial of Metformin in Overweight and Obese Patients with Newly Diagnosed Breast Cancer
- (2014) Kevin Kalinsky et al. CANCER INVESTIGATION
- Insulin, Estrogen, Inflammatory Markers, and Risk of Benign Proliferative Breast Disease
- (2014) C. Catsburg et al. CANCER RESEARCH
- Paradoxic effects of metformin on endothelial cells and angiogenesis
- (2014) Katiuscia Dallaglio et al. CARCINOGENESIS
- Acquired resistance to metformin in breast cancer cells triggers transcriptome reprogramming toward a degradome-related metastatic stem-like profile
- (2014) Cristina Oliveras-Ferraros et al. CELL CYCLE
- Metformin Does Not Affect Cancer Risk: A Cohort Study in the U.K. Clinical Practice Research Datalink Analyzed Like an Intention-to-Treat Trial
- (2014) Konstantinos K. Tsilidis et al. DIABETES CARE
- The prognostic value of metformin for cancer patients with concurrent diabetes: a systematic review and meta-analysis
- (2014) Z.-J. Zhang et al. DIABETES OBESITY & METABOLISM
- Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls
- (2014) C. A. Bannister et al. DIABETES OBESITY & METABOLISM
- Validating drug repurposing signals using electronic health records: a case study of metformin associated with reduced cancer mortality
- (2014) H. Xu et al. JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION
- Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase
- (2014) Anila K. Madiraju et al. NATURE
- Cancer risks from diabetes therapies: Evaluating the evidence
- (2014) Chen Li et al. PHARMACOLOGY & THERAPEUTICS
- Response of Breast Cancer Cells and Cancer Stem Cells to Metformin and Hyperthermia Alone or Combined
- (2014) Hyemi Lee et al. PLoS One
- Cancer biology in diabetes
- (2014) Shi Sen et al. Journal of Diabetes Investigation
- The effect of metformin on breast cancer outcomes in patients with type 2 diabetes
- (2014) Bridget A. Oppong et al. Cancer Medicine
- Diabetes in relation to breast cancer relapse and all-cause mortality in elderly breast cancer patients: a FOCUS study analysis
- (2013) M. Kiderlen et al. ANNALS OF ONCOLOGY
- Theranostic and Molecular Classification of Breast Cancer
- (2013) Kristine M. Cornejo et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Clinical pathological characteristics and prognostic analysis of 1,013 breast cancer patients with diabetes
- (2013) Guofang Hou et al. BREAST CANCER RESEARCH AND TREATMENT
- The effect of metformin on apoptosis in a breast cancer presurgical trial
- (2013) M Cazzaniga et al. BRITISH JOURNAL OF CANCER
- Metformin inhibits growth and enhances radiation response of non-small cell lung cancer (NSCLC) through ATM and AMPK
- (2013) Y Storozhuk et al. BRITISH JOURNAL OF CANCER
- Systematic review and meta-analysis of the association between diabetes mellitus and incidence and mortality in breast and colorectal cancer
- (2013) K. M. J. De Bruijn et al. BRITISH JOURNAL OF SURGERY
- Association of metformin use with cancer incidence and mortality: A meta-analysis
- (2013) Pengpeng Zhang et al. Cancer Epidemiology
- Direct inhibition of hexokinase activity by metformin at least partially impairs glucose metabolism and tumor growth in experimental breast cancer
- (2013) Cecilia Marini et al. CELL CYCLE
- Glucose promotes breast cancer aggression and reduces metformin efficacy
- (2013) Reema Wahdan-Alaswad et al. CELL CYCLE
- Metformin Decreases Circulating Androgen and Estrogen Levels in Nondiabetic Women With Breast Cancer
- (2013) Carlo Campagnoli et al. Clinical Breast Cancer
- Association Between Metformin Therapy and Mortality After Breast Cancer: A population-based study
- (2013) I. C. Lega et al. DIABETES CARE
- Increased Risk of Cognitive Impairment in Patients With Diabetes Is Associated With Metformin
- (2013) E. M. Moore et al. DIABETES CARE
- Metformin and Sulfonylureas in Relation to Cancer Risk in Type II Diabetes Patients: A Meta-analysis using primary data of published studies
- (2013) Bindiya Thakkar et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Metformin reverses multidrug resistance and epithelial–mesenchymal transition (EMT) via activating AMP-activated protein kinase (AMPK) in human breast cancer cells
- (2013) Chen Qu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP
- (2013) Russell A. Miller et al. NATURE
- Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patients
- (2013) L. Sciacca et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth
- (2013) H. A. Hirsch et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clinical pathological characteristics and prognostic analysis of diabetic women with luminal subtype breast cancer
- (2013) Yuanting Xiao et al. TUMOR BIOLOGY
- Latest insights into the risk of cancer in diabetes
- (2013) Hiroshi Noto et al. Journal of Diabetes Investigation
- Simultaneous quantification of metformin and glipizide in human plasma by high-performance liquid chromatography-tandem mass spectrometry and its application to a pharmacokinetic study
- (2012) Ning Li et al. BIOMEDICAL CHROMATOGRAPHY
- Diabetes and breast cancer risk: a meta-analysis
- (2012) P Boyle et al. BRITISH JOURNAL OF CANCER
- Phase I trial of exemestane in combination with metformin and rosiglitazone in nondiabetic obese postmenopausal women with hormone receptor–positive metastatic breast cancer
- (2012) Francisco J. Esteva et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Mitochondrial biogenesis in epithelial cancer cells promotes breast cancer tumor growth and confers autophagy resistance
- (2012) Ahmed F. Salem et al. CELL CYCLE
- Metformin is synthetically lethal with glucose withdrawal in cancer cells
- (2012) Javier A. Menendez et al. CELL CYCLE
- Mitochondrial dysfunction in breast cancer cells prevents tumor growth
- (2012) Rosa Sanchez-Alvarez et al. CELL CYCLE
- Effect of Different Doses of Metformin on Serum Testosterone and Insulin in Non-Diabetic Women With Breast Cancer: A Randomized Study
- (2012) Carlo Campagnoli et al. Clinical Breast Cancer
- Mortality After Incident Cancer in People With and Without Type 2 Diabetes: Impact of metformin on survival
- (2012) C. J. Currie et al. DIABETES CARE
- Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials
- (2012) R. J. Stevens et al. DIABETOLOGIA
- Diabetes increases the risk of breast cancer: a meta-analysis
- (2012) Prue J Hardefeldt et al. ENDOCRINE-RELATED CANCER
- Obesity, type 2 diabetes, and cancer: the insulin and IGF connection
- (2012) Dara Hope Cohen et al. ENDOCRINE-RELATED CANCER
- Diabetes, Metformin, and Breast Cancer in Postmenopausal Women
- (2012) Rowan T. Chlebowski et al. JOURNAL OF CLINICAL ONCOLOGY
- Dual Effect of Metformin on Breast Cancer Proliferation in a Randomized Presurgical Trial
- (2012) Bernardo Bonanni et al. JOURNAL OF CLINICAL ONCOLOGY
- Metformin in cancer: translational challenges
- (2012) Ryan J O Dowling et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- The glucose-deprivation network counteracts lapatinib-induced toxicity in resistant ErbB2-positive breast cancer cells
- (2012) Kakajan Komurov et al. Molecular Systems Biology
- The role of ATM in response to metformin treatment and activation of AMPK
- (2012) Sook Wah Yee et al. NATURE GENETICS
- Zhou et al. reply
- (2012) Kaixin Zhou et al. NATURE GENETICS
- Lapatinib for Advanced or Metastatic Breast Cancer
- (2012) F. L. Opdam et al. ONCOLOGIST
- Cancer Risk in Diabetic Patients Treated with Metformin: A Systematic Review and Meta-analysis
- (2012) Hiroshi Noto et al. PLoS One
- Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer
- (2011) X. He et al. ANNALS OF ONCOLOGY
- Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial
- (2011) Sirwan Hadad et al. BREAST CANCER RESEARCH AND TREATMENT
- Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer
- (2011) Soley Bayraktar et al. CANCER
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Potent anti-proliferative effects of metformin on trastuzumab-resistant breast cancer cells via inhibition of erbB2/IGF-1 receptor interactions
- (2011) Bolin Liu et al. CELL CYCLE
- Lower Risk of Cancer in Patients on Metformin in Comparison With Those on Sulfonylurea Derivatives: Results from a large population-based follow-up study
- (2011) R. Ruiter et al. DIABETES CARE
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Overweight, Obesity, Diabetes, and Risk of Breast Cancer: Interlocking Pieces of the Puzzle
- (2011) C. La Vecchia et al. ONCOLOGIST
- Molecular classification of breast cancer: is it time to pack up our microscopes?
- (2011) Margaret C. Cummings et al. PATHOLOGY
- Promoter-specific effects of metformin on aromatase transcript expression
- (2011) Nirukshi U. Samarajeewa et al. STEROIDS
- Metformin: A Therapeutic Opportunity in Breast Cancer
- (2010) A. M. Gonzalez-Angulo et al. CLINICAL CANCER RESEARCH
- Comment on: Yang et al. (2010) Associations of Hyperglycemia and Insulin Usage With the Risk of Cancer in Type 2 Diabetes: The Hong Kong Diabetes Registry. Diabetes;59:1254-1260
- (2010) D. Simon et al. DIABETES
- Associations of Hyperglycemia and Insulin Usage With the Risk of Cancer in Type 2 Diabetes: The Hong Kong Diabetes Registry
- (2010) X. Yang et al. DIABETES
- Long-Term Metformin Use Is Associated With Decreased Risk of Breast Cancer
- (2010) M. Bodmer et al. DIABETES CARE
- Metformin: Taking away the candy for cancer?
- (2010) Mathilde Jalving et al. EUROPEAN JOURNAL OF CANCER
- Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state
- (2010) Marc Foretz et al. JOURNAL OF CLINICAL INVESTIGATION
- Fasting C-Peptide Levels and Death Resulting From All Causes and Breast Cancer: The Health, Eating, Activity, and Lifestyle Study
- (2010) Melinda L. Irwin et al. JOURNAL OF CLINICAL ONCOLOGY
- Associations of Insulin Resistance and Adiponectin With Mortality in Women With Breast Cancer
- (2010) Catherine Duggan et al. JOURNAL OF CLINICAL ONCOLOGY
- Diabetes Mellitus and Breast Cancer Outcomes: A Systematic Review and Meta-Analysis
- (2010) Kimberly S. Peairs et al. JOURNAL OF CLINICAL ONCOLOGY
- More favorable progesterone receptor phenotype of breast cancer in diabetics treated with metformin
- (2010) Lev M. Berstein et al. MEDICAL ONCOLOGY
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lapatinib monotherapy in patients with relapsed, advanced, or metastatic breast cancer: efficacy, safety and biomarker results from Japanese patients phase II studies
- (2009) M Toi et al. BRITISH JOURNAL OF CANCER
- New Users of Metformin Are at Low Risk of Incident Cancer: A cohort study among people with type 2 diabetes
- (2009) G. Libby et al. DIABETES CARE
- Lapatinib
- (2009) James E. Frampton DRUGS
- Diabetes and cancer
- (2009) Paolo Vigneri et al. ENDOCRINE-RELATED CANCER
- Diabetes in Asia
- (2009) Juliana C. N. Chan et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Diabetes therapy and cancer risk
- (2009) Riccardo Vigneri Nature Reviews Endocrinology
- Breast cancer special types: why bother?
- (2008) JS Reis-Filho et al. JOURNAL OF PATHOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started